Skip to content

Pilot Study of a Mental Health Intervention for children and adults with Developmental & Epileptic Encephalopathies (DEEs)

Pilot Study of a Mental Health Intervention to diagnose and treat psychological and behavioural disorders in children and adults with Developmental & Epileptic Encephalopathies.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000117415
Acronym
MICE-DEE
Enrollment
80
Registered
2025-02-03
Start date
2025-02-10
Completion date
2027-02-02
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Developmental and Epileptic Encephalopathies (DEEs) are the most severe group of epilepsies. Patients have intellectual disability and a range of mental health disorders in more than 70% of individuals, including mood disorders, behavioural problems, psychosis, and autism spectrum disorder; which often go undiagnosed and untreated. Current therapies for epilepsy aim to control seizures but do not address the comorbidities in patients with DEEs. As children with DEEs grow, their mental health comorbidities often eclipse seizures as the problem of greatest concern. This study will pilot the first mental health clinical intervention for children and adults with DEEs. A psychological intervention (MICE) successfully pioneered in the UK has been adapted for adults and children with DEEs (MICE-DEE) to test the feasibility in a pilot study of 40 patients with DEEs compared with 40 patients receiving assessment enhanced standard care.

Interventions

Pilot study of a Mental Health Intervention for Children and Adults with DEEs (MICE-DEE). Our UK collaborators used MATCH-ADTC (Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct problems) in children with epilepsy. MATCH-ADTC is based on principles of cognitive behavioural therapy (CBT) for behaviour problems, anxiety, depression, and trauma. Their intervention, MICE (Mental health Intervention for Children with Epilepsy), modified MATCH-ADTC by incorporating

Pilot study of a Mental Health Intervention for Children and Adults with DEEs (MICE-DEE). Our UK collaborators used MATCH-ADTC (Modular Approach to Therapy for Children with Anxiety, Depression, Trauma or Conduct problems) in children with epilepsy. MATCH-ADTC is based on principles of cognitive behavioural therapy (CBT) for behaviour problems, anxiety, depression, and trauma. Their intervention, MICE (Mental health Intervention for Children with Epilepsy), modified MATCH-ADTC by incorporating additional modules for use with children with epilepsy, including those with mild intellectual disability. Study design: Children (4+ years) and adults with DEEs and mental health disorders will be randomised to either Assessment-Enhanced Standard Care for 26 weeks, or MICE-DEE, a personalized modular psychological therapy, for 16 (±6, minimum of 10) sessions for 26 weeks. This intervention will be delivered entirely to caregivers of normal intellect. Individuals with DEEs will often have severe or profound intellectual disability and will not be able, or asked, to engage in telehealth. The caregivers will attend weekly sessions with the MICE-DEE therapist to develop and practice strategies to ameliorate their child’s mental health problem. Caregivers will then practice these strategies at home and complete weekly check-in measures before each session. The participants will gain access to the MICE-DEE trial via an initial psychological intervention assessment with parents conducted face-to-face where possible. The remaining trial will be delivered by telehealth (zoom or telephone). The intervention will be provided by therapists trained in the MICE-DEE intervention. The MICE-DEE therapists will come from a range of disciplines, including psychologists, epilepsy nurse specialists, mental health workers, research personnel and clinicians. MICE-DEE therapists will receive regular clinical supervision with clinical psychologists or neuropsychologists. The MICE-DEE trial involves a weekly consultation using telehealth. Parents/carers will practise intervention strategies at home and complete weekly check-in measures via email before each session with the therapist. MICE-DEE involves an average of 16 sessions (minimum 10, maximum 22 sessions), within 6 months post-randomisation, with two booster sessions permitted between 6 and 12 months. The time to complete each session is approximately 1 hour, each module involves an average of 16 sessions. Modules included in the MICE-DEE trial include behavioural problems, depression, and anxiety. Each module contains practices: example practices within the ‘behaviour problems’ treatment module include time out, rewards, active ignoring, making a plan, and effective instructions. Each practice is delivered via a 1-hour treatment session that involves psychoeducation and guided practice of therapeutic strategies between the participant and therapist, with homework tasks and additional practice completed outside each session. Strategies to assess adherence to the intervention are incorporated into the weekly consultation using telehealth and completion of the check-ins prior to the consultation. The weekly questionnaires include a parental self-efficacy scale to assess perceived effectiveness in delivering the intervention. The individualised intervention will be tailored to each patient, taking into account the main mental health problem. This will occur depending on the diagnosis determined following completion of the Developmental Behaviour Checklist (DBC-2) and Development and Wellbeing Assessment (DAWBA) assessments. Patients will then be randomised in the pilot study and the appropriate module assigned depending on the diagnoses. Changes in the default treatment sequence are accommodated to address treatment difficulties (eg. when outcome measures collected each week show a poor response), or immediate issues arising during treatment (eg. behavioural escalation) to enable real-time adaptation of the treatment protocol to address the key issue, before recommencing the main problem focus. Clinical judgement will be used throughout to determine whether adaptation to the default treatment sequence for the main mental health problem is required.

Sponsors

University of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator)

Eligibility

Sex/Gender
All
Age
4 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age 4 years or older Diagnosis of a DEE Scored above pre-specified threshold on the DBC-2 for mental health symptoms Meeting DSM-5 or ICD-10 diagnostic criteria for a mental health disorder (eg. depression, anxiety, disruptive behaviour or trauma) Have a parent or regular carer of normal intellect willing to participate in MICE-DEE

Exclusion criteria

Insufficient English to access screening measures Refusing to have therapy sessions audio and/or video recorded Actively receiving psychological therapy to treat emotional or behavioural problems at time of initial assessment or intervention phase Presence of active, severe mental health disorder requiring immediate intervention and not suitable for MICE intervention (eg. psychosis, active suicidal ideation). Unable to complete the measures despite all reasonable efforts being made to assist

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026